Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
 shares announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, Feb. 28, 2017 -- The Shareholders Foundation, Inc. announces that a deadline is coming up on March 28, 2017 in the lawsuit that was filed for certain investors in (NYSE:STT) shares against State Street Corp over alleged Securities Laws Violations.
Investors, who purchased shares of State Street Corp (NYSE:STT), have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
On January 18, 2017, the U.S. Department of Justice announced that State Street Corp entered into a deferred prosecution agreement and agreed to pay a $32.3 million criminal penalty to resolve charges that it engaged in a scheme to defraud a number of the bank’s clients by secretly applying commissions to billions of dollars of securities trades. State Street Corp also agreed to offer an equal amount as a civil penalty to the U.S. Securities and Exchange Commission, equaling an aggregate settlement of more than $64 million. State Street Corp admitted the allegations and agreed to a deferred prosecution agreement that requires it to employ an independent corporate compliance monitor for three years.
On January 27, 2017 a lawsuit was filed against State Street Corp over alleged violations of securities laws. The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that State Street engaged in a scheme to defraud a number of its clients by secretly applying commissions to billions of dollars of securities trades, that State Street’s billing practices relied on unsustainable methodologies, that over a 18-year period, approximately $240 million or more of expenses may have been incorrectly invoiced to State Street’s asset servicing clients, that from June 2010 until September 2011, State Street charged clients “substantial” mark-ups without their consent, that as a result, Defendants’ public statements were materially false and misleading at all relevant times.
Those who purchased State Street Corp (NYSE:STT) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108
